- Home
- ORLA vs BHC Comparison
ORLA vs BHC Comparison
Compare ORLA & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- BHC
- Stock Information
- Founded
- ORLA 2007
- BHC N/A
- Country
- ORLA Canada
- BHC Canada
- Employees
- ORLA N/A
- BHC N/A
- Industry
- ORLA Precious Metals
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ORLA Basic Materials
- BHC Health Care
- Exchange
- ORLA Nasdaq
- BHC Nasdaq
- Market Cap
- ORLA 2.3B
- BHC 2.0B
- IPO Year
- ORLA N/A
- BHC N/A
- Fundamental
- Price
- ORLA $11.10
- BHC $4.59
- Analyst Decision
- ORLA Buy
- BHC Hold
- Analyst Count
- ORLA 2
- BHC 5
- Target Price
- ORLA $6.13
- BHC $7.20
- AVG Volume (30 Days)
- ORLA 1.3M
- BHC 2.6M
- Earning Date
- ORLA 05-09-2025
- BHC 04-30-2025
- Dividend Yield
- ORLA N/A
- BHC N/A
- EPS Growth
- ORLA N/A
- BHC N/A
- EPS
- ORLA 0.27
- BHC N/A
- Revenue
- ORLA $343,918,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- ORLA $158.56
- BHC $4.92
- Revenue Next Year
- ORLA $13.13
- BHC $2.36
- P/E Ratio
- ORLA $38.79
- BHC N/A
- Revenue Growth
- ORLA 47.20
- BHC 8.53
- 52 Week Low
- ORLA $3.24
- BHC $3.96
- 52 Week High
- ORLA $11.95
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- ORLA 56.93
- BHC 34.85
- Support Level
- ORLA $10.68
- BHC $4.63
- Resistance Level
- ORLA $11.81
- BHC $4.86
- Average True Range (ATR)
- ORLA 0.56
- BHC 0.25
- MACD
- ORLA -0.07
- BHC -0.00
- Stochastic Oscillator
- ORLA 63.89
- BHC 6.02
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the South Railroad and Lewis gold projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.